比利时药品早期临时报销政策及对我国的启示

The early temporary reimbursement of Belgium and its enlightenment to China

比利时针对优先药物的医保报销,已形成较为完善的早期临时报销(ETR)政策,在提高优先药物可及性的同时减轻用药者的负担。本文系统剖析了ETR所适用的药物标准、情形以及ETR方案。结合我国现阶段医疗保险管理制度,本文从对临床急需药品探索多样化报销路径、制定未满足的临床需求清单、加强药品管理不同部门间协作这3个层面提出具体的完善建议,以期对提高新药在医保准入与报销方面的效率与质量有所启发。

For the reimbursement of the priority medicines,the government of Belgium has formed a relatively perfect policy the early temporary reimbursement (ETR).While the accessibility of priority medicines is improved,the burden of patients is also reduced.This paper systematically analyzes the standards and situation of applicable drugs accorded with the requirement of ETR and the scheme of ETR.Combining with the medical insurance management system of China,this paper puts forward concrete suggestions from three aspects of exploring diversified ways of reimbursement for medicines in urgent need,creating a list of unmet clinical needs and strengthening the cooperation among related administration departments,aiming to improve the efficiency and quality of the medical insurance access and reimbursement of new drugs.